Study: HAGLR Gene Linked To Cancer, Neurodegenerative Disorders and COPD

Target Name: HAGLR

NCBI ID: G401022

HAGLR

Study: HAGLR Gene Linked To Cancer, Neurodegenerative Disorders and COPD

HAGLR (MIR7704HG), a highly-drug-resistant gene, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and chronic obstructive pulmonary disease (COPD). HAGLR is a gene that encodes a protein known as heat shock factor-3 (HSF-3), which plays a critical role in stress responses and has been linked to a number of diseases.

One of the most significant findings related to HAGLR is its role in cancer. Studies have shown that high levels of HAGLR are associated with an increased risk of cancer development. For example, a study published in the journal \"Oncogene\" found that individuals with certain genetic variations in the HAGLR gene were significantly more likely to develop pancreatic cancer.

Another potential drug target related to HAGLR is its role in neurodegenerative disorders. The buildup of aggregates of the HAGLR protein has been linked to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This is because the HAGLR protein is involved in the formation of these aggregates, which can cause damage to nerve cells and lead to the symptoms associated with neurodegenerative disorders.

In addition to its potential links to cancer and neurodegenerative disorders, HAGLR has also been identified as a potential biomarker for COPD. Studies have shown that individuals with HAGLR gene variants are more likely to have persistent airway obstruction and other symptoms associated with COPD. This is because the HAGLR protein is involved in the regulation of airway diameter, and individuals with certain HAGLR gene variants may have reduced airway capacity, leading to symptoms of COPD.

Overall, the study of HAGLR has significant implications for the development of new treatments for a variety of diseases. By targeting the HAGLR protein, researchers may be able to develop drugs that can treat cancer, neurodegenerative disorders, and COPD, among other conditions.

Protein Name: HOXD Antisense Growth-associated Long Non-coding RNA

The "HAGLR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HAGLR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets